Moderna have announced they are expected to begin human trials on a two-in one vaccine targeting Covid and the flu.
The trials, which are expected to start in approximately two months’ time, will determine the effectiveness of a vaccine designed to protect against the flu and Covid.
Phase one of the trial for the new vaccine has begun with a second triple-threat vaccine targeting the flu, Covid and a contagious lung infection also on the way.
Stay up-to-date on the latest news with The National Briefing - keeping you in the loop with the nation’s breaking news as it hits.